Skip to main content
Watch Insiders
PCSA filings

Corporate insider profile

Patrick Lin Filing Activity

Latest reported as Chief Business - Strategy Off of Processa Pharmaceuticals, Inc. (PCSA).

Purchase filings
6
Reported companies
1
Net open-market value
$24,392
Latest transaction
Jun 30, 2026

Affiliated corporations

Reported company relationships

PCSALatest reported

Processa Pharmaceuticals, Inc.

Chief Business - Strategy Off

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 30, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy OffOpen Market Purchase2,106$1.93$4,065
Jun 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy OffOpen Market Purchase1,831$2.22$4,065
May 29, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy OffOpen Market Purchase1,582$2.57$4,066
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium